Immunology

Latest News

Christopher Sayed, MD, UNC School of Medicine
Subcutaneous HS Therapy: Efficacy and Safety Insights

December 12th 2024

In the continuation of our discussion with Chris Sayed, MD, University of North Carolina at Chapel Hill Department of Dermatology, he discusses the benefits of subcutaneous treatment of hidradenitis suppurativa, the chronic inflammatory skin condition.

Asembia Top 5 Thumbnail
ICYMI: Highlights From Asembia 2024

December 3rd 2024

Christopher Sayed, MD, UNC Chapel Hill
BE HEARD Trials Highlight Efficacy of Bimekizumab in Hidradenitis Suppurativa

November 26th 2024

FDA | Image Credit: © Deni-stock.adobe.com
FDA Approves Bimekizumab in Hidradenitis Suppurativa

November 20th 2024

Psoriatic arthritis | Image Credit: © MQ-Illustrations-stock.adobe.com
New PsA Data Highlight Long-Term Benefits of Bimekizumab

November 19th 2024

Exploring a Chronic and Painful Inflammatory Skin Disease

Join us as Dr. Iltefat Hamzavi shares insights into hidradenitis suppurativa. Learn about its signs, symptoms, differential diagnosis, and treatment strategies, as Dr. Hamzavi highlights the impact on patients and families.

Join us as Dr. Iltefat Hamzavi shares insights into hidradenitis suppurativa. Learn about its signs, symptoms, differential diagnosis, and treatment strategies, as Dr. Hamzavi highlights the impact on patients and families.

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo